Part B News
03/13/2023
CMS recently published an FAQ document on the use of drug waste modifiers. The resource addresses how the modifiers affect Medicare policy, to which products they can be appended, billing concerns and more.
03/06/2023
Two recent transactions in the multibillion dollar range suggest a change in direction toward more investment in primary care. While fears of consolidation grow, you may also find good news for physician practice owners who want to sell out but keep some control over the destiny of their patients.
03/06/2023
Stay on top of a series of proposed rules that will impact waivers for controlled substance prescriptions written during telehealth visits. Federal agencies are sharpening a range of policies in anticipation of the end of the COVID-19 public health emergency (PHE), which expires May 11.
03/06/2023
DecisionHealth has revised its tool for office/other outpatient E/M visits (99202-99215) to include encounters performed in the inpatient or observation (99221-99223 and 99231-99236), emergency department (99281-99285), nursing facility (99304-99310) and home or residence (99341-99350) settings and consults (99242-99245 and 99252-99255).
03/06/2023
Question: What are the differences between remote therapeutic monitoring and remote physiologic monitoring and what details should we look for in documentation to report these services with CPT codes?
03/06/2023
On Feb. 13, CMS published an MLN Fact Sheet regarding billing procedures for insulin following the new regulation that limits the Part B coinsurance for a month’s supply of insulin at $35. CMS is instructing providers not to bill for supplies for insulin for July 2023 or subsequent months in advance of July 2023 to ensure patients aren’t charged more than the $35 maximum allowed for that month.
03/06/2023
Trends in annual wellness visits (AWV), billed to Medicare as G0438 and G0439, and the initial preventive physical examination (IPPE), aka Welcome to Medicare visit (G0402), show that while the codes did not prosper in the first year of the COVID crisis in 2020, G0439 pulled out of its tailspin in 2021; the others, however, continued to underperform.
02/27/2023
Take note of an expanded benefit for colorectal cancer (CRC) screening. It’s likely to mean that providers will talk to more patients about the screening, billing staff will collect copays from fewer patients, and if your practice performs non-invasive CRC tests in-house, you’ll see an uptick in lab services.
02/27/2023
A flurry of drug-pricing activity at HHS and CMS shows the agencies looking forward to big changes in what they’ll pay pharmaceutical companies for Medicare drugs. Most of these won’t affect providers and patients directly for some time — except for one shift that will appear as early as April 1 for some practices that dispense Part B drugs.
02/27/2023
You’ll find Medicare’s new and revised rules for hospital visits, nursing facility visits, prolonged services and split/shared visits in CMS 100-04, Change Request 13064, released February 9. The update includes more information on documenting time-based visits but is silent on component-based split/shared billing.

Login

User Name:
Password:
Welcome to the new Part B News Online. If you are a returning user having trouble logging in, please click here.
Back to top